Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sjögren’s syndrome

Fig. 3

Serum proinflammatory cytokine levels of IL-6 (A), TNF-α (B), IL-17 A (C), and anti-inflammatory levels of IL-10 (D) in NOD mice. All data are expressed as mean ± SD. Significance levels in the model group versus blank group are * P < 0.05, ** P < 0.01, and in the drug treatment group versus model group are # P < 0.05, ## P < 0.01 (n = 8)

Back to article page